Table 2.
no ATc | 0.05 ng ml−1 ATc | 0.1 ng ml−1 ATc | 0.2 ng ml−1 ATc | 25 ng ml−1 ATc | |
---|---|---|---|---|---|
MIC (μg ml−1) against M. bovis BCG clpP1-tetoff | |||||
ADEP2 | 16 (8) | 8 (4) | 4 (2) | 2 (0.5) | no growth |
apramycin | 1 | 1 | nd | 1 | no growth |
isoniazid | 0.03 | 0.03 | 0.03 | 0.03 | no growth |
| |||||
MIC (μg ml−1) against M. bovis BCG wt | |||||
ADEP2 | 16 | Nd | nd | nd | 16 |
apramycin | 1 | Nd | nd | nd | 1 |
isoniazid | 0.06 | Nd | nd | nd | 0.06 |
MIC values against M. bovis BCG Pasteur wildtype (wt) and M. bovis BCG Pasteur clpP1-tetoff in the presence of increasing ATc concentrations. In this conditional system clpP1P2 expression is suppressed by ATc resulting in decreased ClpP1P2 protein levels (for further information on strain regulation compare figure S5A). For ease of comparison with table 3, data are arranged with decreasing ClpP levels from left to right. Data in brackets represent the concentration where partial growth inhibition was observed. nd, not determined.